Genetic mapping studies identified ATR as a candidate gene for Seckel syndrome, but its location on the physical map had not been defined. We used the ATR cDNA sequence to identify a 112-kb genomic sequence 4 that in turn retrieved two linked BACs, one of which was located at 147.77 Mb on chromosome 3, Published online 17 March 2003, doi:10.1038/ng1129 Fig. 1 F02-98 cells show an impaired response to DNA damage. a, F02-98 cells were impaired in phosphorylation of H2AX (γH2AX) and p53 Ser15 induced by ultraviolet radiation (UV) but normal in phosphorylation of these substrates after exposure to ionizing radiation (IR). Owing to difficulty in obtaining sufficient material from primary fibroblast cells for western blotting, the phosphorylation of ATR substrates after exposure to DNAdamaging agents was examined by immunofluorescence using phosphospecific antibodies (α-P-Ser15-p53). Phosphorylation was examined after exposure to ionizing radiation (10 Gy) and ultraviolet radiation (5 J m -2 ) 1 h after irradiation. Cells held under low-serum conditions for 5 d before exposure to ultraviolet radiation had an identical response to that of exponentially growing cells (data not shown). b, F02-98 cells were impaired in phosphorylation of hRad17 and Nbs1 induced by ultraviolet radiation (UV). The examination of phosphorylation was carried out as described in a using phosphospecific antibodies (α-PRad17 and α-P-Nbs1). Immunofluorescence was also analyzed using antibodies that recognize endogenous Rad17 and Nbs1 (α-Rad17 and α-Nbs1; right panels) verifying that these proteins were expressed efficiently before and after ultraviolet radiation treatment in F02-98 cells.
Darier disease (DD) is an autosomal-dominant skin disorder characterized by loss of adhesion between epidermal cells (acantholysis) and abnormal keratinization. Recently we constructed a 2.4-Mb, P1-derived artificial chromosome contig spanning the DD candidate region on chromosome 12q23-24.1. After screening several genes that mapped to this region, we identified mutations in the ATP2A2 gene, which encodes the sarco/endoplasmic reticulum Ca2(+)-ATPase type 2 isoform (SERCA2) and is highly expressed in keratinocytes. Thirteen mutations were identified, including frameshift deletions, in-frame deletions or insertions, splice-site mutations and non-conservative missense mutations in functional domains. Our results demonstrate that mutations in ATP2A2 cause DD and disclose a role for this pump in a Ca(2+)-signalling pathway regulating cell-to-cell adhesion and differentiation of the epidermis.
We report that hypofunctional alleles of WNT1 cause autosomal-recessive osteogenesis imperfecta, a congenital disorder characterized by reduced bone mass and recurrent fractures. In consanguineous families, we identified five homozygous mutations in WNT1: one frameshift mutation, two missense mutations, one splice-site mutation, and one nonsense mutation. In addition, in a family affected by dominantly inherited early-onset osteoporosis, a heterozygous WNT1 missense mutation was identified in affected individuals. Initial functional analysis revealed that altered WNT1 proteins fail to activate canonical LRP5-mediated WNT-regulated β-catenin signaling. Furthermore, osteoblasts cultured in vitro showed enhanced Wnt1 expression with advancing differentiation, indicating a role of WNT1 in osteoblast function and bone development. Our finding that homozygous and heterozygous variants in WNT1 predispose to low-bone-mass phenotypes might advance the development of more effective therapeutic strategies for congenital forms of bone fragility, as well as for common forms of age-related osteoporosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.